Rosanne Lane, MAS
- 3Articles
- 73.3KReads
- 2008–2020Active
- 29Collaborators
- 485Citations
About
Rosanne Lane, MAS, has contributed to research published in Psychiatrist.com focusing on treatment approaches for major depressive disorder, including esketamine nasal spray for patients with active suicidal ideation, as well as long-term safety of esketamine combined with oral antidepressants in treatment-resistant depression. Lane has also studied the efficacy and tolerability of oral paliperidone extended-release tablets in acute schizophrenia. Her work spans clinical areas of depression, schizophrenia/schizoaffective disorders, and suicide, with publications from 2008 to 2020.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
